Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

66°
- Newport, VT (05855)
  Today
  
  Showers tapering off early with foggy conditions overnight. Areas of patchy fog. Low around 55F. Winds light and variable. Chance of rain 90%..
  
  Tonight
  
  Showers tapering off early with foggy conditions overnight. Areas of patchy fog. Low around 55F. Winds light and variable. Chance of rain 90%.
  
  Updated: September 17, 2026 @ 6:15 pm
- Full Forecast

Site search

Home
News
Sports
Entertainment
- Calendar
Obituaries
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
- Place an ad
Archives
Best of 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Imunon, Inc. - Common Stock (NQ:IMNN)

1.381 +0.021 (+1.54%)

Streaming Delayed Price Updated: 10:54 AM EDT, Sep 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Imunon, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Preview: Imunon's Earnings ↗

March 27, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

March 04, 2024

We're starting off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday morning!

Via InvestorPlace

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 28, 2024

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

Via Benzinga

Imunon: Q3 Earnings Insights ↗

November 14, 2023

Via Benzinga

Imunon's Earnings Outlook ↗

November 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 28, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 28, 2024

Via Benzinga

Imunon Highlights Early Data From Lead Program In Ovarian Cancer ↗

September 28, 2023

Imunon Inc (NASDAQ: IMNN) announces interim progression-free survival (PFS) and overall survival (OS) data with IMNN-001 in its Phase 1/2 OVATION 2 Study of intraperitoneal IMNN-001 in combination with...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 28, 2023

Via Benzinga

Earnings Outlook For Imunon ↗

August 09, 2023

Via Benzinga

Imunon: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

Imunon, Inc. - Common Stock Earnings Perspective: Return On Capital Employed ↗

March 31, 2023

Via Benzinga

Imunon, Inc. - Common Stock Earnings Preview ↗

March 29, 2023

Via Benzinga

Imunon, Inc. - Common Stock's Return On Capital Employed Overview ↗

December 23, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

April 03, 2023

On Monday, 76 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 30, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 02, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 31, 2023

Via Benzinga

IMUNON Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)

December 14, 2022

From Imunon, Inc.

Via GlobeNewswire

IMUNON Presentation at World Vaccine & Immunotherapy Congress Highlights PLACCINE Preclinical Proof of Concept and Key Competitive Advantages

December 01, 2022

From Imunon, Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Wednesday ↗

November 30, 2022

During Wednesday's session, 107 stocks hit new 52-week lows.

Via Benzinga

IMUNON to Participate in the A.G.P./Alliance Global Partners Virtual Biotech Conference on November 30, 2022 – December 1, 2022

November 22, 2022

From Imunon, Inc.

Via GlobeNewswire

IMUNON Announces Strategic Investment in Transomic Technologies

November 17, 2022

From Imunon, Inc.

Via GlobeNewswire

IMUNON Reports Third Quarter 2022 Financial Results and Provides Business Update

November 14, 2022

From Imunon, Inc.

Via GlobeNewswire

IMUNON Enters into Technology Evaluation Agreement with Acuitas Therapeutics to Evaluate IMUNON’s PLACCINE Plasmid DNA with Acuitas’ Lipid Nanoparticle Delivery System

November 10, 2022

From Imunon, Inc.

Via GlobeNewswire

Imunon to Hold Third Quarter 2022 Financial Results and Business Update Conference Call on Monday, November 14, 2022

November 07, 2022

From Imunon, Inc.

Via GlobeNewswire

Imunon Appoints James E. Dentzer to its Board of Directors

October 03, 2022

From Imunon, Inc.

Via GlobeNewswire

Imunon Reports Partial Results from Ongoing Non-human Primate Study

October 03, 2022

From Imunon, Inc.

Via GlobeNewswire

Imunon Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)

September 29, 2022

From Imunon, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Entertainment
Obituaries
Local Events
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather
California Privacy Notice

Newport Daily Express

NewportVermontDailyExpress.com
178 Hill Street
Newport, VT 05855
Phone: 802-334-6568
Email: editor@newportvermontdailyexpress.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Consent Preferences

Newport, VT (05855)

Today

Tonight

Imunon, Inc. - Common Stock (NQ:IMNN)

All News about Imunon, Inc. - Common Stock

Sections

Services

Newport Daily Express